An Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) in Patients With Breast Cancer
Clinical trial NCT00051779 · COMPLETED
Trial details
- NCT number
- NCT00051779
- Sponsor
- Chugai Pharma USA
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.